Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
Gross margin was 83% for the third quarter of 2023 compared to 79% for the third quarter of 2022.
- Gross margin was 83% for the third quarter of 2023 compared to 79% for the third quarter of 2022.
- Net loss was $(7.6) million for the third quarter of 2023 compared to $(18.8) million for the third quarter of 2022.
- Adjusted EBITDA was $12.3 million for the third quarter of 2023 compared to $(6.1) million for the third quarter of 2022.
- Hims & Hers will host a conference call to review the third quarter 2023 results on November 6, 2023, at 5:00 p.m.